TE_27261
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MER61A |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 170.19 |
| Counts of samples | TCGA_tumor:150; TCGA_normal:0; GTEx:0 |
| TSS | chr13(-):61671419 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_27261.1 | - | Intergenic | Non-coding | Non-coding | chr13(-):61654206,61654226,61671207,61671420 |
| teRNA_27261.2 | - | Intergenic | Non-coding | Non-coding | chr13(-):61632380,61632400,61654174,61654226,61671207,61671420 |
| teRNA_27261.3 | - | Intergenic | Non-coding | Non-coding | chr13(-):61567803,61567823,61654174,61654226,61671207,61671420 |
| teRNA_27261.4 | - | Intergenic | Non-coding | Non-coding | chr13(-):61622778,61622798,61671207,61671420 |
| teRNA_27261.5 | - | Intergenic | Non-coding | Non-coding | chr13(-):61666925,61666945,61671207,61671420 |
| teRNA_27261.6 | - | Intergenic | Non-coding | Non-coding | chr13(-):61654206,61654226,61666813,61666945,61671207,61671420 |
| teRNA_27261.7 | - | Intergenic | Non-coding | Non-coding | chr13(-):61658847,61658867,61671207,61671420 |
| teRNA_27261.8 | - | Intergenic | Non-coding | Non-coding | chr13(-):61654206,61654226,61664093,61664196,61671207,61671420 |
| teRNA_27261.9 | - | Intergenic | Other | MNRHFSKEDIYAANRHMKKCSSSLAIREMQIKTTKRYHLTPVRMAIIKKSGNNRCWRGCGEIGTLLHCWWDCKLLQPLWKTVWRFLRDLELEIPFDPAIPLLGIYPKDYKSCCYKDTCTRMFIAALFTIAKTWNQPKCPTMIDWIKKMWHICTMEYYAAIKNDEFMSFVGTWMKLETIILSKLSQGQKTKHRMFSLIDGN* | chr13(-):61566423,61566443,61567604,61568962,61671207,61671420 |
| teRNA_27261.10 | - | Intergenic | Non-coding | Non-coding | chr13(-):61568942,61568962,61671207,61671420 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
